Aurora Cannabis (ACB) Other Operating Expenses (2018 - 2019)

Aurora Cannabis (ACB) reported Other Operating Expenses of $64.5 million for Q2 2019, up 16.35% quarter-over-quarter from $55.5 million in Q1 2019.

Aurora Cannabis (ACB) Other Operating Expenses (2018 - 2019) Analysis & Trends

Aurora Cannabis (ACB) has 2 years of Other Operating Expenses data on file, last reported at $64.5 million in Q2 2019.

Other Operating Expenses for Q2 2019 came in at $64.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2020 was $64.5 million (down 57.55% YoY), and the FY2025 annual result was $57.0 million, up 2.67% from the prior year.
Other Operating Expenses grew to $64.5 million in Q2 2019 per ACB's latest filing, from $55.5 million in the prior quarter.
Over five years, Other Operating Expenses peaked at $64.5 million in Q2 2019 and troughed at $46.4 million in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn
10	Liquidia	5.63 Bn	5.40 Bn	121.79 Mn

Download Data